The cellular composition of induced sputum in chronic obstructive pulmonary disease

Asthma and chronic obstructive pulmonary disease are characterized by airway inflammation, which can be assessed by bronchoscopic techniques as well as by the analysis of induced sputum. A method to induce sputum with inhaled hypertonic saline was adapted for use in 21 chronic obstructive pulmonary disease (COPD) patients (mean baseline forced expiratory volume in one second (FEV1) 1.60 L, or 54% predicted) and in 16 healthy volunteers. The success rate and safety of the method, were investigated along with the reproducibility of cell counts and differences in cell counts between both groups. All subjects produced adequate samples and the procedure did not alter spirometric values. A marked sputum neutrophilia was noted in patients with COPD (74.9+/-4.7%), whereas mainly macrophages were seen in healthy volunteers (74.0+/-4.0%). Reliability of the cell counts was high, both within investigators (r=0.99 neutrophils, r=0.99 macrophages) and between investigators (r=0.95 neutrophils, r=0.77 macrophages). In patients with COPD, an inverse correlation was noted between percentage of neutrophils and FEV1 (r(s)=-0.48, p<0.05). Immunostaining revealed a large proportion of activated macrophages in both groups. It was concluded that induction of sputum is a safe and reproducible method to study the composition of airway secretions in patients with chronic obstructive pulmonary disease.

This article has been cited by other articles:

				J.-L. Corhay, M. Henket, D. Nguyen, B. Duysinx, J. Sele, and R. Louis Leukotriene B4 Contributes to Exhaled Breath Condensate and Sputum Neutrophil Chemotaxis in COPD Chest, October 1, 2009; 136(4): 1047 - 1054. [Abstract] [Full Text] [PDF]

				D-W. Perng, C-W. Tao, K-C. Su, C-C. Tsai, L-Y. Liu, and Y-C. Lee Anti-inflammatory effects of salmeterol/fluticasone, tiotropium/fluticasone or tiotropium in COPD Eur. Respir. J., April 1, 2009; 33(4): 778 - 784. [Abstract] [Full Text] [PDF]

				T. E. McManus, A-M. Marley, N. Baxter, S. N. Christie, J. S. Elborn, H. J. O'Neill, P. V. Coyle, and J. C. Kidney High levels of Epstein-Barr virus in COPD Eur. Respir. J., June 1, 2008; 31(6): 1221 - 1226. [Abstract] [Full Text] [PDF]

				V. Kim, T. J. Rogers, and G. J. Criner New Concepts in the Pathobiology of Chronic Obstructive Pulmonary Disease Proceedings of the ATS, May 1, 2008; 5(4): 478 - 485. [Abstract] [Full Text] [PDF]

				A. Haegens, J. H. J. Vernooy, P. Heeringa, B. T. Mossman, and E. F. M. Wouters Myeloperoxidase modulates lung epithelial responses to pro-inflammatory agents Eur. Respir. J., February 1, 2008; 31(2): 252 - 260. [Abstract] [Full Text] [PDF]

				D. E. Shaw, M. A. Berry, B. Hargadon, S. McKenna, M. J. Shelley, R. H. Green, C. E. Brightling, A. J. Wardlaw, and I. D. Pavord Association Between Neutrophilic Airway Inflammation and Airflow Limitation in Adults With Asthma Chest, December 1, 2007; 132(6): 1871 - 1875. [Abstract] [Full Text] [PDF]

				T. Yamagata, H. Sugiura, T. Yokoyama, S. Yanagisawa, T. Ichikawa, K. Ueshima, K. Akamatsu, T. Hirano, M. Nakanishi, Y. Yamagata, et al. Overexpression of CD-11b and CXCR1 on Circulating Neutrophils: Its Possible Role in COPD Chest, September 1, 2007; 132(3): 890 - 899. [Abstract] [Full Text] [PDF]

				P. Rytila, M. Plataki, F. Bucchieri, M. Uddin, G. Nong, V. L. Kinnula, and R. Djukanovic Airway neutrophilia in COPD is not associated with increased neutrophil survival Eur. Respir. J., December 1, 2006; 28(6): 1163 - 1169. [Abstract] [Full Text] [PDF]

				T Hirano, T Yamagata, M Gohda, Y Yamagata, T Ichikawa, S Yanagisawa, K Ueshima, K Akamatsu, M Nakanishi, K Matsunaga, et al. Inhibition of reactive nitrogen species production in COPD airways: comparison of inhaled corticosteroid and oral theophylline Thorax, September 1, 2006; 61(9): 761 - 766. [Abstract] [Full Text] [PDF]

				R O'Donnell, D Breen, S Wilson, and R Djukanovic Inflammatory cells in the airways in COPD Thorax, May 1, 2006; 61(5): 448 - 454. [Abstract] [Full Text] [PDF]

				E M Drost, K M Skwarski, J Sauleda, N Soler, J Roca, A Agusti, and W MacNee Oxidative stress and airway inflammation in severe exacerbations of COPD Thorax, April 1, 2005; 60(4): 293 - 300. [Abstract] [Full Text] [PDF]

				J. H. J. Vernooy, J. H. N. Lindeman, J. A. Jacobs, R. Hanemaaijer, and E. F. M. Wouters Increased Activity of Matrix Metalloproteinase-8 and Matrix Metalloproteinase-9 in Induced Sputum From Patients With COPD Chest, December 1, 2004; 126(6): 1802 - 1810. [Abstract] [Full Text] [PDF]

				P. J. Barnes Mediators of Chronic Obstructive Pulmonary Disease Pharmacol. Rev., December 1, 2004; 56(4): 515 - 548. [Abstract] [Full Text] [PDF]

				R A O'Donnell, A Richter, J Ward, G Angco, A Mehta, K Rousseau, D M Swallow, S T Holgate, R Djukanovic, D E Davies, et al. Expression of ErbB receptors and mucins in the airways of long term current smokers Thorax, December 1, 2004; 59(12): 1032 - 1040. [Abstract] [Full Text] [PDF]

				R A O'Donnell, C Peebles, J A Ward, A Daraker, G Angco, P Broberg, S Pierrou, J Lund, S T Holgate, D E Davies, et al. Relationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPD Thorax, October 1, 2004; 59(10): 837 - 842. [Abstract] [Full Text] [PDF]

				T. S. Lapperre, J. B. Snoeck-Stroband, M. M.E. Gosman, J. Stolk, J. K. Sont, D. F. Jansen, H. A.M. Kerstjens, D. S. Postma, and P. J. Sterk Dissociation of Lung Function and Airway Inflammation in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., September 1, 2004; 170(5): 499 - 504. [Abstract] [Full Text] [PDF]

				D.-W. Perng, H.-Y. Huang, H.-M. Chen, Y.-C. Lee, and R.-P. Perng Characteristics of Airway Inflammation and Bronchodilator Reversibility in COPD: A Potential Guide to Treatment Chest, August 1, 2004; 126(2): 375 - 381. [Abstract] [Full Text] [PDF]

				E. Gamble, D. C. Grootendorst, C. E. Brightling, S. Troy, Y. Qiu, J. Zhu, D. Parker, D. Matin, S. Majumdar, A. M. Vignola, et al. Antiinflammatory Effects of the Phosphodiesterase-4 Inhibitor Cilomilast (Ariflo) in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., October 15, 2003; 168(8): 976 - 982. [Abstract] [Full Text] [PDF]

				P.J. Barnes, S.D. Shapiro, and R.A. Pauwels Chronic obstructive pulmonary disease: molecular and cellularmechanisms Eur. Respir. J., October 1, 2003; 22(4): 672 - 688. [Abstract] [Full Text] [PDF]

				K. Kostikas, G. Papatheodorou, K. Psathakis, P. Panagou, and S. Loukides Oxidative Stress in Expired Breath Condensate of Patients With COPD Chest, October 1, 2003; 124(4): 1373 - 1380. [Abstract] [Full Text] [PDF]

				P Montuschi, S A Kharitonov, G Ciabattoni, and P J Barnes Exhaled leukotrienes and prostaglandins in COPD Thorax, July 1, 2003; 58(7): 585 - 588. [Abstract] [Full Text] [PDF]

				R.O. Crapo, R.L. Jensen, and F.E. Hargreave Airway inflammation in COPD: physiological outcome measures and induced sputum Eur. Respir. J., June 1, 2003; 21(41_suppl): 19S - 28s. [Abstract] [Full Text] [PDF]

				J. Domagala-Kulawik, M. Maskey-Warzechowska, I. Kraszewska, and R. Chazan The Cellular Composition and Macrophage Phenotype in Induced Sputum in Smokers and Ex-Smokers With COPD Chest, April 1, 2003; 123(4): 1054 - 1059. [Abstract] [Full Text] [PDF]

				P. Boschetto, M. Miniati, D. Miotto, F. Braccioni, E. De Rosa, I. Bononi, A. Papi, M. Saetta, L.M. Fabbri, and C.E. Mapp Predominant emphysema phenotype in chronic obstructive pulmonary disease patients Eur. Respir. J., March 1, 2003; 21(3): 450 - 454. [Abstract] [Full Text] [PDF]

				J. H. Vernooy, M. Kucukaycan, J. A. Jacobs, N. H. Chavannes, W. A. Buurman, M. A. Dentener, and E. F. Wouters Local and Systemic Inflammation in Patients with Chronic Obstructive Pulmonary Disease: Soluble Tumor Necrosis Factor Receptors Are Increased in Sputum Am. J. Respir. Crit. Care Med., November 1, 2002; 166(9): 1218 - 1224. [Abstract] [Full Text] [PDF]

				Leader of the Working Group: P.L. Paggiaro, Members of the Working Group:, P. Chanez, O. Holz, P.W. Ind, R. Djukanovic, P. Maestrelli, and P.J. Sterk Sputum induction Eur. Respir. J., July 1, 2002; 20(37_suppl): 3S - 8s. [Full Text] [PDF]

				G. W. Chalmers, K. J. MacLeod, L. Thomson, S. A. Little, C. McSharry, and N. C. Thomson Smoking and Airway Inflammation in Patients With Mild Asthma Chest, December 1, 2001; 120(6): 1917 - 1922. [Abstract] [Full Text] [PDF]

				J. TAMAOKI, M. KONDO, H. KURODA, K. AOSHIBA, K. TAKEYAMA, J. NAKATA, and A. NAGAI Validity and Safety of Sputum Induction by Inhaled Uridine 5'-Triphosphate Am. J. Respir. Crit. Care Med., August 1, 2001; 164(3): 378 - 381. [Abstract] [Full Text] [PDF]

				P. E. Silkoff, D. Martin, J. Pak, J. Y. Westcott, and R. J. Martin Exhaled Nitric Oxide Correlated With Induced Sputum Findings in COPD Chest, April 1, 2001; 119(4): 1049 - 1055. [Abstract] [Full Text] [PDF]

				A. PAPI, M. ROMAGNOLI, S. BARALDO, F. BRACCIONI, I. GUZZINATI, M. SAETTA, A. CIACCIA, and L. M. FABBRI Partial Reversibility of Airflow Limitation and Increased Exhaled NO and Sputum Eosinophilia in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1773 - 1777. [Abstract] [Full Text]

				R. A. Peleman, V. Van De Velde, P. R. Germonpré, C. Fleurinck, M. T. Rosseel, and R. A. Pauwels Trovafloxacin Concentrations in Airway Fluids of Patients with Severe Community-Acquired Pneumonia Antimicrob. Agents Chemother., January 1, 2000; 44(1): 178 - 180. [Abstract] [Full Text]